🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

74+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 20 of 74 recruiting trials for “sickle-cell-s-d-punjab-disease

NARecruitingNCT06650813

Adapting the FACETS Program to Sickle Cell Disease

👨‍⚕️ Marie-Claire GAY, Pr, Paris Nanterre University📍 2 sites📅 Started Jan 2025View details ↗
Phase 2RecruitingNCT06635902

Intravenous L-Citrulline for Vaso-occlusive Pain Episode in Sickle Cell Disease

👨‍⚕️ Suvankar Majumdar, MD, Children's National Research Institute📍 1 site📅 Started Dec 2024View details ↗
Phase 4RecruitingNCT07177300

Effectiveness of Nontraditional Hydroxyurea Algorithms: Novel and Clinical Evaluations (ENHANCE)

👨‍⚕️ Charles T. Quinn, Professor of Pediatrics, M.D., M.S., Children's Hospital Medical Center, Cincinnati📍 1 site📅 Started Dec 2024View details ↗
NARecruitingNCT05383911

Empowering Adolescents and Young Adults With Sickle Cell Disease as Partners in Treatment Decision Making (EMPOWER-AYA)

🏥 Nemours Children's Clinic📍 1 site📅 Started Nov 2024View details ↗
Phase 1RecruitingNCT06442761

SCD Stem Cell Mobilization and Apheresis Using Motixafortide

👨‍⚕️ Alexis Leonard, MD, St. Jude Children's Research Hospital📍 2 sites📅 Started Nov 2024View details ↗
NARecruitingNCT06184126

Virtual Reality Devices as an Adjunct to Usual Care for Patients With Sickle Cell Disease Experiencing Vaso-Occlusive Crises

👨‍⚕️ R. Gentry Wilklerson, MD, U of Maryland, Baltimore📍 1 site📅 Started Nov 2024View details ↗
Phase 3RecruitingNCT06439082

A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

🏥 Novartis Pharmaceuticals📍 30 sites📅 Started Oct 2024View details ↗
NARecruitingNCT07001631

Effect of EMDR for Reduction of Pain Interference in Children With Sickle Cell Disease

👨‍⚕️ Karin Fijnvandraat, prof. dr., Amsterdam UMC📍 1 site📅 Started Sep 2024View details ↗
Phase 1, PHASE2RecruitingNCT04774536

Transplantation of Clustered Regularly Interspaced Short Palindromic Repeats Modified Hematopoietic Progenitor Stem Cells (CRISPR_SCD001) in Patients with Severe Sickle Cell Disease

👨‍⚕️ Mark Walters, MD, UCSF Benioff Children's Hospital Oakland📍 2 sites📅 Started Sep 2024View details ↗
RecruitingNCT06477289

Peripheral Arterial Tonometry and Neurocognition in Sickle Cell Disease

👨‍⚕️ Andrew Heitzer, Phd, St. Jude Children's Research Hospital📍 1 site📅 Started Sep 2024View details ↗
NARecruitingNCT06773715

Virtual Reality As Adjunct Therapy for Vaso-Occlusive Pain

🏥 Louisiana State University Health Sciences Center in New Orleans📍 1 site📅 Started Sep 2024View details ↗
NAEnrolling by InvitationNCT06300723

Clinical Study of BRL-101 in Severe SCD

👨‍⚕️ Yongrong Lai, phD, First Affiliated Hospital of Guangxi Medical University📍 1 site📅 Started Jul 2024View details ↗
NARecruitingNCT06139510

Predictors of Pain in Sickle Cell Disease

👨‍⚕️ Martha Kenney, MD, Duke University📍 1 site📅 Started Jul 2024View details ↗
NARecruitingNCT06264700

Applying Directly Observed Therapy to Hydroxyurea to Realize Effectiveness

👨‍⚕️ Susan Creary, MD, MSc, Nationwide Children's Hospital📍 3 sites📅 Started Jul 2024View details ↗
RecruitingNCT06497153

Lung Ultrasound in Pediatric Acute Chest Syndrome

👨‍⚕️ Aurélie HAYOTTE, MD, Assistance Publique - Hôpitaux de Paris📍 1 site📅 Started Jun 2024View details ↗
RecruitingNCT07000747

Molecular and Cellular Basis of Severe Forms of Dengue in Sickle Cell Patients

👨‍⚕️ Maryse Etienne-Julan, MD PhD, CHU de la Guadeloupe📍 1 site📅 Started Jun 2024View details ↗
Enrolling by InvitationNCT06363760

A Long-Term Follow-Up Study of Participants With Sickle Cell Disease or Transfusion Dependent β-Thalassemia Who Received EDIT-301

🏥 Editas Medicine, Inc.📍 18 sites📅 Started Jun 2024View details ↗
EARLY_Phase 1RecruitingNCT06313398

Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling

👨‍⚕️ John F Tisdale, M.D., National Heart, Lung, and Blood Institute (NHLBI)📍 1 site📅 Started May 2024View details ↗
NARecruitingNCT06035939

SMYLS Multi-site Trial

🏥 Medical University of South Carolina📍 1 site📅 Started Apr 2024View details ↗
Phase 2RecruitingNCT06358638

Sickle Cell Disease Transplant Using a Nonmyeloablative Approach for Patients With Anti-donor Red Cell Antibody

👨‍⚕️ Robert Nickel, MD, Children's National Research Institute📍 1 site📅 Started Apr 2024View details ↗
← PreviousPage 2 of 4Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →